Insulin Injection Techniques and Skin Lipodystrophy

Dear Colleagues,

The most frequent local complications of insulin injection are subcutaneous nodules due to incorrect injection techniques called lipodystrophies (LD). Injection into nodules has a series of negative consequences for glycemic control and variability, the frequency of severe hypoglycemia, the economic burden of diabetes, and the quality of life of patients with diabetes.

Guidelines and expert consensuses on injection techniques have appeared in the literature, and case series, surveys, and clinical trials concerning this topic are published continuously. Nevertheless, unfortunately, LD frequency remains dramatically high, mercilessly decreeing a defeat for healthcare providers. Common misconceptions, prejudices, educational deficiencies, and much more influence the incorrect injection behavior of people with diabetes, and a flawed or, even worse, incorrect approach to the problem by healthcare professionals is also, at least partly, responsible for such neglected insulin treatment complications.

These aspects deserve attention and represent a call to integrated action by educators, clinicians, researchers, and people with diabetes to correctly address a behavioral defect responsible for severe short- and long-term consequences for the latter and enormously increased costs for national health systems worldwide.

The Editorial Board invites you to send your contributions in the form of commentaries, short communications, research papers, clinical trials, case series, or surveys to provide readers with a timely update on insulin-induced lipodystrophies.

Dr. Sandro Gentile
Dr. Felix Strollo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diabetology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• diabetes
• insulin treatment
• injection technique
• skin complications
• acquired lipodystrophy